BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15228438)

  • 1. A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma.
    Mudhar HS; Parsons MA; Sisley K; Rundle P; Singh A; Rennie IG
    Histopathology; 2004 Jul; 45(1):1-12. PubMed ID: 15228438
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization.
    Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A
    Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse pigmentation mutants help identify a uveal melanoma oncogene.
    Hayward NK
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):2-3. PubMed ID: 19140886
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma.
    Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG
    Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic, immunohistochemical, and cytogenetic analysis of primary clear cell melanoma of the uvea.
    Verdijk RM; Koopmans AE; Kilic E; Paridaens D; de Klein A
    JAMA Ophthalmol; 2013 Jun; 131(6):814-6. PubMed ID: 23579462
    [No Abstract]   [Full Text] [Related]  

  • 7. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
    Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetics and prognosis for uveal melanoma in Korean patients.
    Lee CS; Lee J; Choi JJ; Yang WI; Yoon JS; Lee SY; Lee SC
    Acta Ophthalmol; 2011 Jun; 89(4):e310-4. PubMed ID: 21310015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.
    Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A
    Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
    van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gamma-interferon in patients with uveal melanoma].
    Likhvantseva VG; Slepova OS; Brovkina AF
    Vestn Oftalmol; 2000; 116(1):26-8. PubMed ID: 10741260
    [No Abstract]   [Full Text] [Related]  

  • 12. Uveal melanoma: prognostication.
    Turell ME; Tubbs RR; Biscotti CV; Singh AD
    Monogr Clin Cytol; 2012; 21():55-60. PubMed ID: 22024584
    [No Abstract]   [Full Text] [Related]  

  • 13. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
    Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K
    Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
    Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
    Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NBS1 expression as a prognostic marker in uveal melanoma.
    Ehlers JP; Harbour JW
    Clin Cancer Res; 2005 Mar; 11(5):1849-53. PubMed ID: 15756009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of the FRO project: chromosomal abnormalities in primary uveal melanoma.
    Cools D; Debiec-Rychter M; Parys-Van Ginderdeuren R; Hagemeijer-Hausman A; Van den Oord J; Spileers W
    Bull Soc Belge Ophtalmol; 2000; (278):67-70. PubMed ID: 11761564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal aberrations in iris melanomas.
    Mensink HW; Vaarwater J; de Keizer RJ; de Wolff-Rouendaal D; Mooy CM; de Klein A; Paridaens D
    Br J Ophthalmol; 2011 Mar; 95(3):424-8. PubMed ID: 20881029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of bcl-2, Ki-67 and p-53 in uveal melanomas].
    Krvavica A; Talan-Hranilović J; Belicza M
    Acta Med Croatica; 2008 Jul; 62(3):267-71. PubMed ID: 18843846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic investigations of posterior uveal melanoma.
    Hovland PG; Trempe C
    Semin Ophthalmol; 2005; 20(4):231-8. PubMed ID: 16352494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.